Logo 1 Logo 2

Clinical Trial Details

Trial ID: L3635
Source ID: NCT00005669
Associated Drug: Metformin Hcl
Title: Metformin to Treat Obesity in Children With Insulin Resistance
Acronym:
Status: COMPLETED
Study Results: YES
Results: https://ClinicalTrials.gov/show/NCT00005669/results
Conditions: Hyperinsulinemia|Obesity
Interventions: DRUG: Metformin HCL|DRUG: Placebo
Outcome Measures: Primary: Changes in Body Weight as Determined by Body Mass Index-standard Deviation Score (BMI-SDS)., Change in Body Mass Index standard deviation score (BMI-SDS) determined using tables created by the CDC in 2000. BMI-SDS is a unitless transformation of the body mass index (measured in kg divided by the squared height in meters) using the L M S method. Possible values range from -3 to +3. See http://www.cdc.gov/growthcharts/percentile_data_files.htm for details., 6 months | Secondary: Change in Body Weight as Determined by BMI, Change in body weight as determined by body mass index (kg/m2), 6 months|Change in Body Weight, Change in body weight (kg), 6 months|Change in Body Fat by DEXA, Change in body fat mass by Dual Energy X-Ray Absorptiometry (kg), 6 months|Change in Body Fat by Bod Pod, Change in body fat mass measured by air displacement plethysmography (kg), 6 months
Sponsor/Collaborators: Sponsor: Jack Yanovski, M.D. | Collaborators: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Gender: ALL
Age: CHILD
Phases: PHASE2
Enrollment: 100
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Start Date: 2000-05
Completion Date: 2011-05
Results First Posted: 2011-04-07
Last Update Posted: 2015-05-08
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, 20892, United States
URL: https://clinicaltrials.gov/show/NCT00005669